The BCR-ABL positive CML (Chronic Myeloid Leukaemia) cells also lower the expression of mlh1 and pms2 and induce point mutations thus affecting the mismatch repair mechanisms34,35. The gene discussed is MLH1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.